openPR Logo

Press Releases from DelveInsight Business Research (25 total)

Cutaneous Squamous Cell Carcinoma – US market revenue will increase by double …

The estimated total number of incident cases of Cutaneous Squamous Cell Carcinoma (cSCC) in the US is expected to reach 713,294 by 2025 as per the latest report of DelveInsight. Non-melanoma skin cancer is the most common skin cancer in the United States. It is broadly classified into Basal cell carcinoma (BCC) and Squamous cell carcinoma (SCC). Basal cell carcinoma accounts for 75-80% of non-melanoma cancers and Squamous cell carcinoma

Pulmonary Arterial Hypertension (PAH) – Reaching a Global Market Size up to US …

Prevalent cases of PAH in the 7MM (US, Germany, Spain, Italy, France, United Kingdom and Japan) are around 70,000 in 2016, out of which females are the ones to be majorly affected with this disease, accounting for 70% of the prevalent cases. Among the three major sub-types of PAH i.e., idiopathic PAH, heritable PAH, and disease associated PAH, at least 30% prevalent population suffers from idiopathic PAH. Classified under the WHO

PD-1 and PD-L1 Inhibitors Competitive Landscape, Pipeline and Market Analysis, 2 …

Programmed Death 1 (PD-1) and Programmed Death Ligand 1 (PD-L1) is the most talked about immuno-oncology target. Programmed Death 1 (PD-1) is an immune inhibitory receptor expressed on several immune cells, particularly cytotoxic T cells. Therapeutics that blocks this interaction has demonstrated promising clinical activity in several tumor types. PD-L1 not only provides the immune escape of tumor cells but also stimulate apoptosis switch on activated T cells. According to

Cutaneous T-Cell Lymphoma– US to have the lion’s share among the 7MM’s

Cutaneous T-Cell Lymphoma market size in 7MM’s is estimated to increase at a CAGR of 1.6% for the forecasted period (2013-2025), as per the latest report of DelveInsight. CTCL is a group of lympho proliferative disorders characterized by localization of neoplastic T lymphocytes to the skin. Collectively, CTCL is classified as a type of non-Hodgkin lymphoma (NHL). It is the most common type of skin lymphoma. Out of every 4

PD-1 and PD-L1 inhibitors- Rising with existing marketed and drugs

Programmed Death 1 (PD-1) and Programmed Death Ligand 1 (PD-L1) is the most talked about immuno-oncology target. Programmed Death 1 (PD-1) is an immune inhibitory receptor expressed on several immune cells, particularly cytotoxic T cells. Therapeutics that blocks this interaction has demonstrated promising clinical activity in several tumor types. PD-L1 not only provides the immune escape for tumor cells but also stimulate apoptosis switch on activated T cells. According to

Pharmaceutical Market Research Reports!!

Offering Mid-Year Discounts on Pharmaceutical Market Research Reports It's the time to get an edge over Competitors! Mid-Year Discount Upto 30% Off on all Reports covering more than 750 indications across all therapeutic areas. DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. We support companies by providing end to end comprehensive solutions to improve their performance and in making the long lasting decision for their businesses.With

Chemotherapy Induced Neutropenia (CIN) – Market Insights, Epidemiology and Mar …

DelveInsight’s Chemotherapy Induced Neutropenia (CIN) https://www.delveinsight.com/chemotherapy-induced-neutropenia-nbsp-market-insights-epidemiology-and-market-forecast-2023-5254-p.php – Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Chemotherapy Induced Neutropenia (CIN) for the seven major markets i.e., United States, Europe (France, Germany, Italy, Spain, UK) and Japan in ten major indications at risk of CIN i.e., Breast Cancer, Leukemia, Prostate Cancer, Lung Cancer, Cervical Cancer, Pancreatic Cancer, Colorectal Cancer, Ovarian

Alpha- Antitrypsin Deficiency (AATD) – Market Insights, Epidemiology and Marke …

DelveInsight’s ‘Alpha Antitrypsin Deficiency – Market Insights, Epidemiology, and Market Forecast-2023’ report provides an overview of the Alpha Antitrypsin Deficiency and global market size of the Alpha Antitrypsin Deficiency for the United States, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan. The Report provides a comprehensive review of the market trends, drivers, barriers, key company profiles including its business and product developments. Alpha Antitrypsin Deficiency is the

PD-1 and PD-L1 inhibitors – Competitive Landscape, Pipeline and Market Analysi …

DelveInsight‘s report, “PD-1 and PD-L1 inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2017” gives the comprehensive insights on the PD-1 and PD-L1 Inhibitors. The report provides the analysis on the worldwide therapeutic market of PD-1 and PD-L1 inhibitors including information of Marketed molecules, detailed profiling of Pipeline assets and their pathways. The report covers the therapeutics assessment of pipeline molecules by the mechanism of action (MoA), route of administration (RoA),

Natural Killer Cells Therapies- Competitive Landscape, Technology and Pipeline A …

DelveInsight Report, “Natural Killer Cells Therapies- Competitive Landscape, Technology and Pipeline Analysis, 2017”, emphasizes on the currently active NK cell products in research and development. The Report covers 20+ companies, which are active in this field with 40+ products and many different technologies. This report covers NK cell-based therapies along with drugs that augment (enhance or activate) the NK cells. The Report provides in-depth analysis of the Natural Killer Cell-based

Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Tec …

DelveInsight‘s Report, “Chimeric Antigen Receptor (CAR) T-cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2017” emphasizes on the currently active CAR-T cell products in research and development. The Report covers the 68+ companies, which are active in this field including 29+ leading companies with 123+ products targeting 44+ different antigens and 15+ different technologies. The Report provides in-depth analysis on the CAR-T cell profiles covering pre-clinical and clinical studies, Collaborations details

Microbiome-Competitive Landscape, Technology and Pipeline Analysis, 2017

DelveInsight’s, “Microbiome-Competitive Landscape, Technology and Pipeline Analysis, 2017”, the report provides comprehensive insights about microbiome based therapeutic pipeline products. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under this category. This report provides information on the microbiome based therapeutic development dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed,

Hemophilia- Market Insights, Epidemiology and Market Forecast -2023-7MM

DelveInsight’s “Hemophilia- Market Insights, Epidemiology and Market Forecast-2023-7MM” Reports provides an overview of the disease and global market size of the Hemophilia for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data for the prevalent cases of Hemophilia from 2013-2023. According to DelveInsight, the market size for Hemophilia of 7MM is estimated to be USD XX Million by 2023 at a

Immune Checkpoints Activators: Competitive Landscape, Technology and Pipeline An …

DelveInsight’s, “Immune Checkpoints Activators – Competitive Landscape, Technology and Pipeline Analysis, 2017”, the report provides comprehensive insights about pipeline drugs across this Mechanism of action. The key objective of the report is to establish the understanding for all the pipeline drugs that fall under Immune Checkpoints Activators. This report provides information on the therapeutic development based on Immune Checkpoints Activation mechanism dealing with 3 Phase II, 16 Phase I drugs and

Fibromyalgia - Market Insights, Epidemiology and Market Forecast-2023

DelveInsight expertise has expanded from an initial focus on Pipeline & Marketed Reports to Market Forecasting and Epidemiology Reports. Fibromyalgia - Market Insights, Epidemiology and Market Forecast-2023, report provides an insight on the forecast of a indication over a period of time which helps an organization to better understand the business development strategies from present and futuristic point of view. Fibromyalgia - Market Insights, Epidemiology and Market Forecast-2023, provides clients with

Obsessive Compulsive Disorder (OCD) - Pipeline Insights, 2016

DelveInsight, the leading market research and consulting company has added new report Obsessive Compulsive Disorder (OCD) - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this our research expertise provides our clients with up to date information of market till date order has been placed. The Indication pipeline Insight Reports provides client with details Obsessive Compulsive Disorder (OCD)

Ulcerative Colitis (UC)-Market Insights, Epidemiology and Market Forecast-2020

DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. DelveInsight expertise has expanded from an initial focus on Pipeline & Marketed Reports to Market Forecasting and Epidemiology Reports. Ulcerative Colitis (UC)-Market Insights, Epidemiology and Market Forecast-2020, report provides

Idiopathic Pulmonary Fibrosis (IPF) - Market Insights, Epidemiology and Market F …

DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. DelveInsight expertise has expanded from an initial focus on Pipeline & Marketed Reports to Market Forecasting and Epidemiology Reports. Idiopathic Pulmonary Fibrosis (IPF) - Market Insights, Epidemiology

Non-Hodgkin’s Lymphoma (NHL) - Market Insights, Epidemiology and Market Size F …

DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. DelveInsight expertise has expanded from an initial focus on Pipeline & Marketed Reports to Market Forecasting and Epidemiology Reports. Non-Hodgkin’s Lymphoma (NHL) - Market Insights, Epidemiology and Market Size

Pulmonary Arterial Hypertension (PAH) - Market Insights, Epidemiology and Market …

DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. DelveInsight expertise has expanded from an initial focus on Pipeline & Marketed Reports to Market Forecasting and Epidemiology Reports. Pulmonary Arterial Hypertension (PAH) - Market Insights, Epidemiology and Market

Respiratory Syncytial Virus (RSV) Infections-Market Insights, Epidemiology and M …

DelveInsight expertise has expanded from an initial focus on Pipeline & Marketed Reports to Market Forecasting and Epidemiology Reports. Respiratory Syncytial Virus (RSV) Infections-Market Insights, Epidemiology and Market Forecast-2020, report provides an insight on the forecast of a indication over a period of time which helps an organization to better understand the business development strategies from present and futuristic point of view. Respiratory Syncytial Virus (RSV) Infections-Market Insights, Epidemiology and Market

Indication-Market Insights, Epidemiology and Market Forecast- 2010-2020, A Delve …

DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. The database of DelveInsight currently has over 3000 reports which elaborate the domains of Indication Insight, Mechanism of Action, Drug Insights and API Insights. In addition to that,

Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Comp …

DelveInsight, the leading market research and consulting company has added a new report “Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016” to its portfolio. The Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016 report provides the client with details on the ongoing enterprises and the upcoming business opportunities related to new interventions. It comprehensively includes : • 215+ products and 50+ different technologies along

Signal Transducer And Activator Of Transcription 3 (STAT3) Inhibitors Pipeline I …

DelveInsight, the leading market research and consulting company has added new report STAT3 inhibitors-Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this DelveInsight’s research expertise provides the clients with up to date information of market till date order has been placed. The Indication pipeline Insight Reports provides client with details on STAT3 Inhibitors Pipeline products across the globe.

Indication-Market Insights, Epidemiology and Market Forecast- 2010-2020

DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. The database of DelveInsight currently has over 3000 reports which elaborate the domains of Indication Insight, Mechanism of Action, Drug Insights and API Insights. In addition to that,